155 related articles for article (PubMed ID: 1970692)
1. Lymphocyte populations of non-scleronodular Hodgkin's disease subtypes in different stages of lymphocyte depletion. An immunophenotypic and quantitative study.
Valente G; Ferrara P; Stramignoni A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 58(4):289-94. PubMed ID: 1970692
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
Borowitz MJ; Croker BP; Metzgar RS
Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
4. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
Lee YT
Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
[TBL] [Abstract][Full Text] [Related]
5. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
Timens W; Visser L; Poppema S
Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
7. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.
Poppema S
Am J Pathol; 1989 Aug; 135(2):351-7. PubMed ID: 2675617
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
9. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.
Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R
Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944
[TBL] [Abstract][Full Text] [Related]
10. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
11. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
12. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
Hudnall SD; Patel J; Schwab H; Martinez J
Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
[TBL] [Abstract][Full Text] [Related]
13. Functional heterogeneity of CD4+ T lymphocytes: two subpopulations with counteracting immunoregulatory functions identified with the monoclonal antibodies WR16 and WR19.
Moore K; Nesbitt AM
Immunology; 1987 Jun; 61(2):159-65. PubMed ID: 2954898
[TBL] [Abstract][Full Text] [Related]
14. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
Hudnall SD; Betancourt E; Barnhart E; Patel J
Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
[TBL] [Abstract][Full Text] [Related]
15. [Hodgkin's disease--immunological aspects].
Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
17. Quantitative study of T and B lymphocytes in Hodgkin's disease.
Bensa JC; Micouin C; Schaerer R; Sotto JJ; Hollard D
Biomedicine; 1977 Apr; 26(2):137-44. PubMed ID: 326312
[TBL] [Abstract][Full Text] [Related]
18. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
Schmidt U; Herbst J; Metz KA; Leder LD
J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
Coles FB; Cartun RW; Pastuszak WT
Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
